El-Shalakany A H, Kamel K M, Ismail A M, Salah L, El-Deen Fahmy S S, El-Deen Ammar E
Gynaecologic Oncology Unit, Ain Shams University Medical School, Cairo, Egypt.
Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1918-26. doi: 10.1111/j.1525-1438.2006.00718.x.
The purpose of this study is to evaluate the immunohistochemical detection of telomerase enzyme and estrogen receptor (ER) and progesterone receptor (PGR) in gestational trophoblastic neoplasia (GTN) and its clinical significance. Formalin-fixed paraffin blocks for 30 patients (24 with molar pregnancy, 3 with choriocarcinoma, and 3 with placental site trophoblastic tumor) as cases and six products of conception samples from patients with incomplete abortion as controls were included in the study. Immunohistochemical detection of the telomerase catalytic protein and ER and PGR was carried out using streptavidin-biotin-peroxidase method. All control tissues were negative for telomerase and ER expression, while five of six were PGR positive. Significant positive telomerase expression was detected in all gestational trophoblastic tumors (three of six partial moles, 12 of 18 complete moles, three of three choriocarcinomas, and two of three placental site trophoblastic tumors). Nine of 24 molar pregnancies were followed by GTN. Molar pregnancies followed by GTN were associated with higher serum beta-hCG (human chorionic gonadotrophic hormone), larger uterine size for gestational age, negative ER expression, negative PGR expression, and positive telomerase expression. All patients with molar pregnancy with negative telomerase expression (9 of 24) showed spontaneous regression after evacuation. Positive telomerase expression and its immunohistochemical detection are associated with the development of GTN. Negative telomerase expression is highly predictive of postmolar spontaneous regression. Patients with molar pregnancies with negative telomerase expression can be saved the long-term follow-up. ER and PGR expression do not show a significantly different pattern in molar tissues, while negative expression is associated with developing GTN. Cautions on the use of postmolar hormonal contraception may be unjustified.
本研究的目的是评估免疫组织化学检测端粒酶以及雌激素受体(ER)和孕激素受体(PGR)在妊娠滋养细胞肿瘤(GTN)中的情况及其临床意义。本研究纳入了30例患者的福尔马林固定石蜡块(24例葡萄胎、3例绒毛膜癌和3例胎盘部位滋养细胞肿瘤作为病例)以及6例不全流产患者的妊娠产物样本作为对照。采用链霉亲和素-生物素-过氧化物酶法对端粒酶催化蛋白、ER和PGR进行免疫组织化学检测。所有对照组织端粒酶和ER表达均为阴性,而6例中有5例PGR呈阳性。在所有妊娠滋养细胞肿瘤中均检测到显著的端粒酶阳性表达(6例部分性葡萄胎中有3例、18例完全性葡萄胎中有12例、3例绒毛膜癌全部、3例胎盘部位滋养细胞肿瘤中有2例)。24例葡萄胎中有9例继发GTN。继发GTN的葡萄胎与更高的血清β-人绒毛膜促性腺激素(hCG)、大于孕周的子宫大小、ER阴性表达、PGR阴性表达以及端粒酶阳性表达有关。所有端粒酶表达阴性的葡萄胎患者(24例中有9例)清宫后均出现自发消退。端粒酶阳性表达及其免疫组织化学检测与GTN的发生有关。端粒酶阴性表达高度预示葡萄胎后自发消退。端粒酶表达阴性的葡萄胎患者可免于长期随访。ER和PGR在葡萄胎组织中的表达模式无显著差异,而阴性表达与GTN的发生有关。对葡萄胎后使用激素避孕的担忧可能并无依据。